Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population

Cancer Epidemiology Biomarkers and Prevention

Volumn 5, Issue 8, 1996, Pages 627-630

  Zhang, Lian ^a   Blot, William J ^b   You, Wei Cheng ^a,c   Chang, Yun Sheng ^d   Kneller, Robert W ^c   Jin, Mao Lin ^a   Li, Ji You ^a   Zhao, Lei ^a   Liu, Wei Dong ^e   Zhang, Jin Song ^a   Ma, Jun Ling ^d   Samloff, I Michael ^f   Correa, Pelayo ^g   Blaser, Martin J ^h   Xu, Guang Wei ^a   Fraumeni Jr , Joseph F ^c  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Weifang Medical Institute   (China)

^e Linqu Public Health Bureau   (China)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g LOUISIANA STATE UNIVERSITY   (United States)

^h VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIBODY DETECTION; ARTICLE; ATROPHIC GASTRITIS; CHINESE; CHRONIC GASTRITIS; FEMALE; GASTRITIS; HELICOBACTER PYLORI; HIGH RISK POPULATION; HUMAN; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PRECANCER; PREVALENCE; PRIORITY JOURNAL; STOMACH CANCER; STOMACH CARCINOGENESIS;

ADULT; ANTIBODIES, BACTERIAL; BIOLOGICAL MARKERS; CHINA; CROSS-SECTIONAL STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; LOGISTIC MODELS; MIDDLE AGED; PEPSINOGENS; PRECANCEROUS CONDITIONS; STOMACH NEOPLASMS;

EID: 15844409931     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Taylor, D. N., and Blaser, M. J. The epidemiology of Helicobacter pylori infection. Epidemiol. Rev., 13: 42-59, 1991.
2. Correa, P. Is gastric carcinoma an infectious disease? N. Engl. J. Med., 325: 1170-1171, 1991.
3. Correa, P. Human gastric carcinoma: a multistep and multifactorial process. Cancer Res., 52; 6735-6740, 1992.
4. You, W. C., Blot, W. J., Li, J. Y., Chang, Y. S., Jin, M. L., Kneller, W. R., Zhang, L., Han, Z. X., Zeng, X. R., Liu, W. D., Zhao, L., Correa, P., Fraumeni, J. F., Jr., and Xu, G. W. Precancerous gastric lesions in a population at high risk of stomach cancer. Cancer Res., 53: 1317-1321, 1993.
5. Kneller, W. R., You, W. C., Chang, Y. S., Liu, W. D., Zhang, L., Zhao, L., Xu, G. W., Fraumeni, J. F., Jr., and Blot, W. J. Cigarette smoking and other risk factors for progression of precancerous stomach lesions. J. Natl. Cancer Inst., 84: 1261-1266, 1992.
6. You, W. C., Blot, W. J., Zhang, L., Kneller, W. R., Li, J. Y., Jin, M. L., Chang, Y. S., Zeng, X. R., Zhao, L., Fraumeni, J. F., Jr., Xu, G. W., and Samloff, M. I. Serum pepsinogen in relation to precancerous gastric lesions in a population at high risk of gastric cancer. Cancer Epidemiol., Biomarkers & Prev., 2: 113-117, 1993.
7. Markwell, M. A., Haar, S. M., Beiber, L. L., and Tolbert, N. E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem., 87: 206-210, 1978.
8. Perez-Perez, G. I., Dworkin, B. M., Chodus, J. E., Blaser, M. J. Campylobacter pylori antibodies in humans. Ann. Intern. Med., 109: 11-17, 1988.
9. Breslow, N. E., and Day, N. E. Statistical Methods in Cancer Research: The Analysis of Case-Control Studies. IARC Scientific Publ. No. 32, Lyon, France, 1980.
10. Blaser, M. J., and Parsonnet, J. Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J. Clin. Invest., 94: 4-8, 1994.
11. Blaser, M. J. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation: a "slow" bacterial infection. Gastroenterology, 102: 720-727, 1992.
12. Guarner, J., Mohar, A., Parsonnet, J., and Halperin, D. The association of Helicobacter pylori with gastric cancer and preneoplastic gastric lesions in Chiapas, Mexico. Cancer (Phila.), 71: 297-301, 1993.
13. Farinati, F., Valiante, F., Germana, B., DellaLibera, G., Buffa, R., Mugge, M., Plebani, M., DiMario, V., Naccarator, F. Prevalence of Helicobacter pylori infection in patients with precancerous changes and gastric cancer. Eur. J. Cancer Prev., 2: 321-326, 1993.
14. Kuiper, E. J., Pérez-Pérez, G. I., Meuwissen, S. G., and Blaser, M. J. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J. Natl. Cancer Inst., 87: 1777-1780, 1995.
15. Mitchell, H. M., Li, N. Y., Hu, P. J., Liu, Q., Chen, M., Du, G., Wang, Z., Lee, A., and Hazell, S. L. Epidemiology of Helicobacter pylori in southern China: identification of early childhood as the critical period of acquisition. J. Infect. Dis., 166: 149-153, 1992.
16. Mendall, M. A., Goggin, P. M., Molineaux, N., Levy, J., Toosy, T., Strachan, D., and Northfield, T. C. Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet, 339: 896-897, 1992.
17. Sitas, F., Forman, D., Yarnell, J. W. G., Burr, M. L., Elwood, P. C., Pedley, S., and Marks, K. J. Helicobacter pylori infection rates in relation to age and social class in a population of Welsh men. Gut, 32: 25-28, 1991.
18. The Gastrointestinal Physiology Working Group. Helicobacter pylori and gastritis in Peruvian patients: relationship to socioeconomic level, age, and sex. Gastroenterology, 85: 819-823, 1990.
19. Klein, P. D., Gastrointestinal Physiology Working Group, Graham, D. Y., Gaillour, A., Opekun, A. R., and Smith, E. O. Water source as risk factor for Helicobacter pylori infection in Peruvian children. Lancet, 337: 1503-1506, 1991.
20. Palli, D., Decarli, A., Cipriani, F., Sitas, F., Forman, D., Amadori, D., Avellini, C., Giacosa, A., Manca, P., Russo, A., Samloff, I. M., Fraumeni, J. F., Jr., Blot, W. J., and Buiatti, E. Helicobacter pylori antibodies in areas of Italy at varying gastric cancer risk. Cancer Epidemiol., Biomarkers & Prev., 2: 37-40, 1993.
21. Sierra, R., Munoz, N., Pena, A., Biemond, I., Van Duijin, V., Lamers, C., Teuchmann, S., Hernandez, S., and Correa, P. Antibodies to Helicobacter pylori and pepsinogen levels in children from Costa Rica: comparison of two areas with different risks for stomach cancer. Cancer Epidemiol., Biomarkers & Prev., 1: 449-454: 1992.
22. Hunter, F., Correa, P., Fontham, E., Ruiz, B., Sobhan, M., and Samloff, I. M. Serum pepsinogen as markers of response to Helicobacler pylori gastritis. Dig. Dis. Sci., 38: 2081-2086, 1993.
23. Parsonnet, J., Samloff, I. M., Nelson, L., Orentreich, V., Vogelman, J., and Friedman, G. Helicobacter pylori, pepsinogen, and risk for gastric adenocarci-noma. Cancer Epidemiol., Biomarkers & Prev., 2: 461-466, 1993.
24. Sitas, F., Smallwood, R., Jewell, D., Millard, P., Newell, D., Meuwissen, S., Moses, S., Zwiers, A., Forman, D. Serum anti-Helicobacter pylori IgG antibodies and pepsinogen A and C as serologic markers of chronic atrophic gastritis. Cancer Epidemiol., Biomarkers & Prev., 2: 119-124, 1993.